why choose us

First received: February 08, 2024

Clinical Trial: Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cervix Cancer

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

Brief Summary: This study investigates the pharmacokinetics of Artesunate (AS) and dihydroartemisinin (DHA), the active metabolite of Artesunate, following intravaginal use at the dosing and frequency being studied for cervical precancer treatment.A secondary objective is to investigate safety among study participants.

Read more